Dr. Michael Braun

After completion of his PhD studies in Microbiology and Molecular Biology, Michael joined the global pharmaceutical industry beginning 2004. After working for four years in global Drug Regulatory Affairs, he was part of the founding team of the Exalon GmbH.  Exalon is a service provider company and specialized in drug regulatory operations – mainly publishing and submission of electronic submissions in eCTD format. Michael is Managing Partner and responsible for the management of many eCTD lifecycle dossiers covering multiple countries and regions. He also is the primary consultant at Exalon regarding XEVMPD / Article 57 database.